Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02752074 |
|---|---|
| Brief Title: | A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301) |
| First Submitted : | April 22, 2016 |
| First Submitted that Met QC Criteria : | April 22, 2016 |
| First Posted : | April 26, 2016 (Estimate) |
| Results First Submitted : | February 26, 2019 |
| Results First Submitted that Met QC Criteria : | May 13, 2019 |
| Results First Posted : | May 15, 2019 |
| Last Update Submitted that Met QC Criteria : | August 14, 2020 |
| Last Update Posted : | August 27, 2020 |